Hongye Lu | Medicine and Dentistry | Distinguished Scientist Award

Posted on by Phenomenological Research Awards

Assoc. Prof. Dr. Hongye Lu | Medicine and Dentistry | Distinguished Scientist Award 

Dean Assistant at Zhejiang University | China

Assoc. Prof. Dr. Hongye Lu is a leading researcher in dentistry and oral microbiome science, recognized for integrating clinical research with translational and digital innovation. With advanced academic training and extensive research experience, his work focuses on implantology, peri-implantitis, microbiome–host interactions, and biomaterials. He has produced high-impact scholarly contributions and guided multidisciplinary research initiatives. His academic influence is reflected by 729 citations, an h-index of 15, and an i10-index of 19, underscoring his sustained scientific excellence and global research impact.

Citation Metrics

800

600

400

200

0

Citations
729

h-index
15

i10-index
19

Featured Publications

Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award

Posted on by Phenomenological Research Awards

Dr. Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award 

Professor at Yonsei University College of Medicine | South Korea

Dr. Taeyoung Kyong is a medical academic and clinician recognized for expertise in hospital medicine and inpatient care. His education and professional training underpin a strong foundation in internal medicine and clinical research. He has extensive experience integrating patient-centered practice with system-based healthcare improvement. His research interests focus on hospitalist-led care models, diabetes management, quality improvement, and digital health applications. Overall, Dr. Taeyoung Kyong’s work reflects a sustained commitment to advancing evidence-based inpatient medicine and healthcare excellence.

View ORCID

Featured Publications

Seung Hyeun Lee | Medicine and Dentistry | Research Excellence Award

Posted on by Phenomenological Research Awards

Prof. Dr. Seung Hyeun Lee | Medicine and Dentistry | Research Excellence Award

Professor at Kyung Hee University | South Korea

Prof. Dr. Seung Hyeun Lee is a leading academic and clinician-scientist recognized for significant contributions to medicine through high-impact translational and clinical research. He holds advanced medical and doctoral training and has developed a strong academic profile through progressive roles in medical education, clinical leadership, and multidisciplinary research environments. His professional experience reflects sustained engagement in investigator-led and collaborative studies addressing complex clinical challenges. Prof. Dr. Seung Hyeun Lee’s research interests focus on lung cancer, cancer immunology, biomarkers, targeted therapies, and immunotherapy, with an emphasis on translating scientific discoveries into improved clinical practice. His scholarly productivity includes 98 published documents, generating 1,101 citations across 1,036 citing documents, and an h-index of 19, highlighting both the quality and consistency of his work. He is actively involved in peer review and international research collaboration, contributing to the advancement of evidence-based medicine. Overall, Prof. Dr. Seung Hyeun Lee exemplifies research excellence through academic leadership, impactful scholarship, and a sustained commitment to advancing medical science.

Citation Metrics (Scopus)

1200

900

600

300

0

Citations
1,101

Documents
98

h-index
19

Featured Publications

Lukas Prantl | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Dr. Lukas Prantl | Medicine and Dentistry | Best Researcher Award

Applied Stem Cell Research Center at Universität Regensburg | Germany

Prof. Dr. Lukas Prantl is an accomplished academic leader and internationally recognized expert in plastic, aesthetic, and reconstructive surgery, currently serving at the University of Regensburg, Germany. His career reflects a strong blend of clinical innovation, academic excellence, and translational research impact. Educated in medicine and advanced surgical sciences across prestigious European institutions, he holds dual doctoral degrees and a master’s in health business administration, which support his interdisciplinary approach to healthcare leadership. Throughout his professional journey, he has established and directed advanced centers dedicated to plastic, hand, and reconstructive surgery, as well as the Applied Stem Cell Research Center, fostering groundbreaking research in regenerative medicine. His scientific interests focus on adipose-derived stem cells, tissue regeneration, microcirculation, and innovative reconstructive techniques that integrate stem cell technology into clinical applications. Among his notable contributions is the development of the Cell Enriched Lipotransfer method, a pioneering advancement that enhances the success rate of fat grafting and tissue restoration. His prolific academic record includes 412 peer-reviewed publications, 7,550 citations from 6,310 documents, and an h-index of 40, reflecting the global impact and recognition of his research. Beyond his scientific achievements, he has held leadership positions in major national and international surgical societies, contributing to the advancement of standards, education, and ethics in surgery. As an editor and reviewer for leading medical journals and funding bodies, his expertise continues to guide the development of innovative research and surgical techniques worldwide. His commitment to academic mentorship and the integration of evidence-based medicine into practice has shaped new generations of clinicians and researchers. Through his exceptional contributions to clinical excellence, scientific discovery, and institutional leadership, Prof. Dr. Lukas Prantl stands as a driving force in shaping the future of regenerative and reconstructive medicine, continually pushing the boundaries of surgical science and patient-centered innovation.

Profile: Scopus | Orcid | Google Scholar

Featured Publications:

  • Chrobot, N., Unbehaun, P., Frank, K., Hartmann, Prantl, L. (2025). Smartphone-based 3D surface imaging: A new frontier in digital breast assessment? Journal of Clinical Medicine.

  • Neuwieser, H., Jami, N. V. S., Meier, Prantl, L. (2025). Interpreting venous and arterial ulcer images through the Grad-CAM lens: Insights and implications in CNN-based wound image classification. Diagnostics.

  • Schimanski, T., Scheel-Platz, Prantl, L. (2025). CELT Fat increases the metabolic activity as well as the SVF-yield significantly when compared to CELT fat, even after cryopreservation with DMSO. Cells.

  • Loucas, R., Loucas, Prantl, L. (2025). Histology and immunohistochemistry of adipose tissue: A scoping review on staining methods and their informative value.

  • Diesch, S., Frank, K., Brebant, Prantl, L. (2025). Subject-reported satisfaction after cell-enriched lipotransfer (CELT) for lip augmentation. Aesthetic Plastic Surgery.

  • Biermann, N., Eibl, D., Mueller, Prantl, L. (2024). Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy–the prospective-randomized MAYDAY-trial.

  • Zocchi, M.Prantl, L. (2024). Potential benefits of adipose-derived SVF and MSCs to regenerate damaged tissues from alloplastic synthetic materials.

  • Kuehlmann, B., Bonham, C. Gurtner,Prantl, L. (2023). MMP9 as a potential biomarker in human implant-induced fibrotic capsules: A systematic analysis and biomarker study.

  • Knoedler, L., Odenthal, J. F., Prantl, Knoedler, S. A. (2023). Artificial Intelligence-Enabled simulation of gluteal augmentation: A helpful tool in preoperative outcome simulation.

  • Diesch, S., Anders, M., Prantl, Brébant, V. (2023). Factors influencing the shape, size, symmetry and scar of the nipple-areola complex after bilateral reduction mammoplasty.

Baye Dagnew Mekonnon | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Baye Dagnew Mekonnon | Medicine and Dentistry | Best Researcher Award 

Doctor at Menzies institute for Medical Research | Australia

Dr. Baye Dagnew Mekonnon is a dedicated medical researcher and academic with expertise in epidemiology, public health, and chronic disease management, particularly focusing on sleep, pain, and quality of life in neurological and metabolic conditions. He earned his Ph.D. in Medical Studies (Epidemiology) from the University of Tasmania, Australia, where his thesis on “Sleep and Pain in Multiple Sclerosis” produced five original research contributions and advanced the understanding of symptom burden in people with multiple sclerosis. He also holds a Master of Science degree in Medical Physiology from Jimma University, Ethiopia, and a Bachelor of Science in Public Health from the University of Gondar. Over the course of his career, he has accumulated more than eight years of teaching, clinical, and research experience, serving as a lecturer, MSc supervisor, and internal examiner at the University of Gondar before joining the Menzies Institute for Medical Research in Australia. His professional journey includes active involvement in large-scale projects such as the Australian Multiple Sclerosis Longitudinal Study and global collaborations through the Global Burden of Disease initiative. Dr. Baye Dagnew Mekonnon has authored over 70 peer-reviewed publications in reputable journals, contributing significantly to the fields of epidemiology, neurology, sleep research, and chronic disease epidemiology, with his work widely cited in international literature. His methodological expertise spans survey design, advanced statistical modeling, longitudinal and mixed-methods research, and data analysis using multiple software platforms, alongside substantial experience in ethics applications and governance. His research interests lie in exploring the intersections between sleep, pain, comorbidities, and mental health in chronic disease populations, with an emphasis on translating evidence into patient-centered interventions and health policies. In addition, he has engaged in research translation projects, including the development of educational resources for people with multiple sclerosis, while also presenting his work at national and international conferences. Dr. Baye Dagnew Mekonnon’s scholarship demonstrates a strong balance of academic rigor, innovation, and community relevance, underpinned by a collaborative and impact-driven approach. With his proven research excellence, teaching experience, and international collaborations, he is poised to continue making influential contributions to global health research, advancing understanding of complex chronic conditions, and shaping the future of epidemiological studies worldwide.

Profile: Google Scholar

Featured Publications:

  • Dagnew, B. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. Journal of the American College of Cardiology, Cited by: 11,252.

  • Dagnew, B. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, Cited by: 3,050.

  • Dagnew, B. (2021). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health, Cited by: 1,104.

  • Dagnew, B. (2021). Hearing loss prevalence and years lived with disability,findings from the Global Burden of Disease Study 2019. The Lancet, Cited by: 1,051.

  • Dagnew, B. (2020). The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study. Injury Prevention, 26, Cited by: 268.

  • Dagnew, B. (2021). Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Respiratory Medicine, Cited by: 218.

  • Dagnew, B. (2021). Measuring routine childhood vaccination coverage in 204 countries and territories, a systematic analysis for the Global Burden of Disease Study 2020, Release 1. The Lancet, Cited by: 188.